Our group has previously demonstrated that HH-GLI signaling regulates the expression of ATP-binding cassette transporters (ABC transporters), which are correlated to multidrug resistance in cancer cells, providing a rationale for the consideration of the HH-GLI pathway as a therapeutic target in CRC [20]. This evidence concerns the gene ABCA4 and cancer.